Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

A Phase I Randomized, Double-blind, Placebo-controlled Study — 2023 Double Blind Clinical Trial | BudProfiles

Home

Studies

A Phase I Randomized, Double-blind, Placebo-contro...

PositiveDouble Blind Clinical Trial2023

A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Diabetes Metabolic Syndrome

Related Studies

Inconclusive

Role of Lupinus Arboreus Extract in Cannabis-Induced Psychotic Behaviors in Wistar Rats

2025·Animal Study -

Inconclusive

CANNABIS NA GERIATRIA E GERONTOLOGIA: ALZHEIMER

2025·Review/Other

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

Positive

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

2025·Laboratory Study -

Inconclusive

Cannabinoid exposure during pregnancy: consequences for growth, memory and prefrontal cortex integrity in Wistar Rats

2025·Animal Study -

Positive

Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer’s disease through CB1 activation and inflammation modulation

2025·Animal Study -

Cannabinoids

Cannabidiol

Organ Systems

Endocrine System

Study Details

Type: Double Blind Clinical Trial
Year: 2023
Study ID: #2023013